Search
for

    Research

    3 / 1000+ results

      research Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health

      4 citations , February 2025 in “Pharmaceuticals”
      In this study, voglibose, commonly used for diabetes management, was found to reduce melanin synthesis and inhibit melanogenic signaling pathways in B16F10 melanoma cells, suggesting it could be repurposed for treating hyperpigmentation disorders with confirmed topical safety in human tests.
      XEDAR Activates the Non-Canonical NF-κB Pathway

      research XEDAR activates the non-canonical NF-κB pathway

      18 citations , August 2015 in “Biochemical and Biophysical Research Communications”
      This study found that the XEDAR receptor can activate the non-canonical NF-kB pathway involving p100 processing, which is regulated by interactions with TRAF proteins and specific kinases.